Ulcerative Colitis; Study: MLN02 produced significant improvement: 1
Ulcerative Colitis; Study: MLN02 produced significant improvement: 1
About this item
Full title
Ulcerative Colitis; Study: MLN02 produced significant improvement: 1
Publisher
Atlanta: NewsRx
Journal title
Gastroenterology Week, 2003, p.41
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
More information
Scope and Contents
Contents
Results from a separate phase II study of MLN02 in patients with mild to moderate [Crohn] disease, which were initially announced last fall, were also presented at the meeting. In this study of 185 patients, those treated with the higher dose (2.0 mg/kg) of MLN02 showed a statistically significant improvement in remission rates compared to placebo,...
Alternative Titles
Full title
Ulcerative Colitis; Study: MLN02 produced significant improvement: 1
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_237322385
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_237322385
Other Identifiers
ISSN
1543-6756
E-ISSN
1543-6748
How to access this item
Log in as a Library member
